{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:55:45Z","timestamp":1790780145992,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"37","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41388-018-0317-x","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T11:47:45Z","timestamp":1526903265000},"page":"5127-5135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":168,"title":["Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer"],"prefix":"10.1038","volume":"37","author":[{"given":"Sara","family":"Al Habyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Szymborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"McCaffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"317_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fonc.2013.00256","volume":"3","author":"N Ahmed","year":"2013","unstructured":"Ahmed N, Stenvers KL. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol. 2013;3:256.","journal-title":"Front Oncol"},{"key":"317_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177:1053\u201364.","journal-title":"Am J Pathol"},{"key":"317_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","volume":"25","author":"LG Hudson","year":"2008","unstructured":"Hudson LG, Zeineldin R, Stack MS. Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis. 2008;25:643\u201355.","journal-title":"Clin Exp Metastasis"},{"key":"317_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/PGP.0b013e31820d20ba","volume":"30","author":"M Kobel","year":"2011","unstructured":"Kobel M, Turbin D, Kalloger SE, Gao D, Huntsman DG, Gilks CB. Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sites. Int J Gynecol Pathol. 2011;30:366\u201371.","journal-title":"Int J Gynecol Pathol"},{"key":"317_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-359","volume":"12","author":"M Wintzell","year":"2012","unstructured":"Wintzell M, Hjerpe E, Avall Lundqvist E, Shoshan M. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal sub-populations in freshly isolated ovarian cancer ascites. BMC Cancer. 2012;12:359.","journal-title":"BMC Cancer"},{"key":"317_CR6","first-page":"2525","volume":"30","author":"D Koensgen","year":"2010","unstructured":"Koensgen D, Freitag C, Klaman I, Dahl E, Mustea A, Chekerov R, et al. Expression and localization of e-cadherin in epithelial ovarian cancer. Anticancer Res. 2010;30:2525\u201330.","journal-title":"Anticancer Res"},{"key":"317_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrc3432","volume":"13","author":"E Kipps","year":"2013","unstructured":"Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13:273\u201382.","journal-title":"Nat Rev Cancer"},{"key":"317_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrclinonc.2015.224","volume":"13","author":"S Narod","year":"2016","unstructured":"Narod S. Can advanced-stage ovarian cancer be cured? Nat Rev Clin Oncol. 2016;13:255\u201361.","journal-title":"Nat Rev Clin Oncol"},{"key":"317_CR9","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/cas.12987","volume":"107","author":"S Kim","year":"2016","unstructured":"Kim S, Kim B, Song YS. Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer. Cancer Sci. 2016;107:1173\u20138.","journal-title":"Cancer Sci"},{"key":"317_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046858","volume":"7","author":"A Latifi","year":"2012","unstructured":"Latifi A, Luwor RB, Bilandzic M, Nazaretian S, Stenvers K, Pyman J, et al. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. PLoS ONE. 2012;7:e46858.","journal-title":"PLoS ONE"},{"key":"317_CR11","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1172\/JCI69815","volume":"124","author":"RA Davidowitz","year":"2014","unstructured":"Davidowitz RA, Selfors LM, Iwanicki MP, Elias KM, Karst A, Piao H, et al. Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. J Clin Invest. 2014;124:2611\u201325.","journal-title":"J Clin Invest"},{"key":"317_CR12","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/ijc.24188","volume":"124","author":"KL Sodek","year":"2009","unstructured":"Sodek KL, Ringuette MJ, Brown TJ. Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer. 2009;124:2060\u201370.","journal-title":"Int J Cancer"},{"key":"317_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ygyno.2008.11.032","volume":"113","author":"K Shield","year":"2009","unstructured":"Shield K, Ackland ML, Ahmed N, Rice GE. Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol Oncol. 2009;113:143\u20138.","journal-title":"Gynecol Oncol"},{"key":"317_CR14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1593\/neo.07472","volume":"9","author":"ML Puiffe","year":"2007","unstructured":"Puiffe ML, Le Page C, Filali-Mouhim A, Zietarska M, Ouellet V, Tonin PN, et al. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia. 2007;9:820\u20139.","journal-title":"Neoplasia"},{"key":"317_CR15","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1038\/onc.2014.264","volume":"34","author":"Q Cai","year":"2015","unstructured":"Cai Q, Yan L, Xu Y. Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells. Oncogene. 2015;34:3315\u201324.","journal-title":"Oncogene"},{"key":"317_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jcp.21240","volume":"213","author":"N Ahmed","year":"2007","unstructured":"Ahmed N, Thompson EW, Quinn MA. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol. 2007;213:581\u20138.","journal-title":"J Cell Physiol"},{"key":"317_CR17","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1172\/JCI87252","volume":"126","author":"M Yin","year":"2016","unstructured":"Yin M, Li X, Tan S, Zhou HJ, Ji W, Bellone S, et al. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest. 2016;126:4157\u201373.","journal-title":"J Clin Invest"},{"key":"317_CR18","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/sj.onc.1209821","volume":"26","author":"NA Cody","year":"2007","unstructured":"Cody NA, Ouellet V, Manderson EN, Quinn MC, Filali-Mouhim A, Tellis P, et al. Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p. Oncogene. 2007;26:618\u201332.","journal-title":"Oncogene"},{"key":"317_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep05646","volume":"4","author":"S Xu","year":"2014","unstructured":"Xu S, Yang Y, Dong L, Qiu W, Yang L, Wang X, et al. Construction and characteristics of an E-cadherin-related three-dimensional suspension growth model of ovarian cancer. Sci Rep. 2014;4:5646.","journal-title":"Sci Rep"},{"key":"317_CR20","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ng.3573","volume":"48","author":"A McPherson","year":"2016","unstructured":"McPherson A, Roth A, Laks E, Masud T, Bashashati A, Zhang AW, et al. Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer. Nat Genet. 2016;48:758\u201367.","journal-title":"Nat Genet"},{"key":"317_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nrc3789","volume":"14","author":"CL Buchheit","year":"2014","unstructured":"Buchheit CL, Weigel KJ, Schafer ZT. Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat Rev Cancer. 2014;14:632\u201341.","journal-title":"Nat Rev Cancer"},{"key":"317_CR22","first-page":"194","volume":"55","author":"HJ Allen","year":"1987","unstructured":"Allen HJ, Porter C, Gamarra M, Piver MS, Johnson EA. Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions. Exp Cell Biol. 1987;55:194\u2013208.","journal-title":"Exp Cell Biol"},{"key":"317_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neo.2017.04.002","volume":"19","author":"Y Klymenko","year":"2017","unstructured":"Klymenko Y, Johnson J, Bos B, Lombard R, Campbell L, Loughran E, et al. Heterogeneous cadherin expression and multicellular aggregate dynamics in ovarian cancer dissemination. Neoplasia. 2017;19:549\u201363.","journal-title":"Neoplasia"},{"key":"317_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcdb.2016.08.028","volume":"64","author":"H Zhou","year":"2016","unstructured":"Zhou H, Neelakantan D, Ford HL. Clonal cooperativity in heterogenous cancers. Semin Cell Dev Biol. 2016;64:79\u201389.","journal-title":"Semin Cell Dev Biol"},{"key":"317_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1158\/2159-8290.CD-14-1101","volume":"5","author":"M Zhang","year":"2015","unstructured":"Zhang M, Tsimelzon A, Chang CH, Fan C, Wolff A, Perou CM, et al. Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer. Cancer Discov. 2015;5:520\u201333.","journal-title":"Cancer Discov"},{"key":"317_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/1078-0432.CCR-08-1233","volume":"15","author":"E Katz","year":"2009","unstructured":"Katz E, Skorecki K, Tzukerman M. Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell sub-populations. Clin Cancer Res. 2009;15:70\u201380.","journal-title":"Clin Cancer Res"},{"key":"317_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3126","volume":"4","author":"S Domcke","year":"2013","unstructured":"Domcke S, Sinha R, Levine DA, Sander C, Schultz N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun. 2013;4:2126.","journal-title":"Nat Commun"},{"key":"317_CR28","first-page":"5379","volume":"43","author":"TC Hamilton","year":"1983","unstructured":"Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, et al. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 1983;43:5379\u201389.","journal-title":"Cancer Res"},{"key":"317_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/(SICI)1098-2744(199903)24:3<218::AID-MC8>3.0.CO;2-A","volume":"24","author":"AP Manning","year":"1999","unstructured":"Manning AP, Mes-Masson AM, Seymour RJ, Tetrault M, Provencher DM, Tonin PN. Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites. Mol Carcinog. 1999;24:218\u201325.","journal-title":"Mol Carcinog"},{"key":"317_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ccr.2012.10.003","volume":"22","author":"L McCaffrey","year":"2012","unstructured":"McCaffrey L, Montalbano J, Mihai C, Macara IG. Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell. 2012;22:601\u201314.","journal-title":"Cancer Cell"},{"key":"317_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-59745-443-8_8","volume":"140","author":"NE Timmins","year":"2007","unstructured":"Timmins NE, Nielsen LK. Generation of multicellular tumor spheroids by the hanging-drop method. Methods Mol Med. 2007;140:141\u201351.","journal-title":"Methods Mol Med"},{"key":"317_CR32","first-page":"1","volume":"4","author":"H Vankelecom","year":"2009","unstructured":"Vankelecom H. Fixation and paraffin-embedding of mouse tissues for GFP visualization. Cold Spring Harb Protoc. 2009;4:1\u20132.","journal-title":"Cold Spring Harb Protoc"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0317-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0317-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0317-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:12:03Z","timestamp":1684617123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0317-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":32,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0317-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"14 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}